MedCity News -- Cranial and facial implant maker OsteoSymbionics LLC has received a warning letter from the Food and Drug Administration for failing to follow industry manufacturing standards. The FDA listed five violations, most of which seem minor and are related to quality control and record-keeping issues, in a Nov. 30 letter sent to OsteoSymbionics CEO Cynthia Brogan.
